GlassScriptPhysician profile
Rolland Luplow
NPI 1063415131
$8,655.95
in general payments reported to CMS, 2019-2025
49 companies · $24.70 in 2025
The $24.70 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,176 · 2020: $1,329 · 2021: $1,369 · 2022: $2,038 · 2023: $1,658 · 2024: $62.28 · 2025: $24.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,744.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $738.36 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $603.41 | 2019-2023 | |
| Lilly USA, LLC | $576.37 | 2019-2023 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $576.29 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $564.76 | 2019-2023 | Jardiance |
| Amgen INC. | $486.48 | 2019-2024 | Evenity, Prolia, Repatha |
| Astellas Pharma US INC | $453.21 | 2019-2023 | Myrbetriq, Veozah |
| Abbvie INC. | $452.12 | 2020-2023 | |
| Allergan, INC. | $329.80 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $317.19 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $265.99 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $264.90 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $258.39 | 2019-2022 | |
| Abbott Laboratories | $253.95 | 2019-2025 | Freestyle Libre 3 |
| Nestle Healthcare Nutrition INC. | $228.80 | 2020-2021 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolland Luplow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.